We’ll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and ...

Twenty-one companies in the healthcare sector released their quarterly results in the week ending August 1. With this, over ...

The India-United Kingdom Comprehensive Economic and Trade Agreement, or CETA, raises several questions regarding India’s ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

As we approach the 10th anniversary of the amendment to Federal Rule of Civil Procedure 26(b)(1), which called for “proportionality” of discovery requests and responses, it is appropriate to provide ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an ...

The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.

Design software company Figma just went public in the hottest IPO of the year. Here's what its biggest investors' stakes are ...